SCHEMBL2377324

SCHEMBL2377324

C1C2C[N+]12.C1C[N]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083 0.71
Hydrochloric Acid SCHEMBL3262873 0.66
SCHEMBL5855559 0.61
SCHEMBL1419 0.61
SCHEMBL3273283 0.58 NOS3 (0.30)
SCHEMBL9808297 0.58 NOS3 (0.30)
SCHEMBL206353 0.58 NOS3 (0.30)
SCHEMBL495581 0.58
SCHEMBL4294 0.58
SCHEMBL6575355 0.58 NOS3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399204-A1 POTENT AND SELECTIVE INHIBITORS OF IRAK4 Dana-Farber Cancer Institute, Inc. (US) 2024-07-17 EP disclosed
US-20240217983-A1 GPR119 AGONISTS KALLYOPE, INC. 2024-07-04 US disclosed
EP-4334289-A1 NOVEL HETEROCYCLIC COMPOUNDS, COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF Organon R&D Finland Ltd (FI) 2024-03-13 EP disclosed
EP-4320129-A1 GPR119 AGONISTS Kallyope, Inc. (US) 2024-02-14 EP disclosed
EP-4313985-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE Equinorm Ltd (FI) 2024-02-07 EP disclosed
EP-3871673-B1 NOVEL INDAZOLE COMPOUND OR SALT THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2024-01-03 EP disclosed
US-11834467-B2 Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors 1ST Biotherapeutics, Inc. (KR) 2023-12-05 US disclosed
US-20230365557-A1 IMIDAZOPYRIDINYL COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISORDERS 1ST Biotherapeutics, Inc. (KR) 2023-11-16 US disclosed
US-11802126-B2 Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders 1ST Biotherapeutics, Inc. (KR) 2023-10-31 US disclosed
US-20230339978-A1 COMPOUNDS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISORDERS 1ST Biotherapeutics, Inc. (KR) 2023-10-26 US disclosed
EP-3692023-A1 BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS 1st Biotherapeutics, Inc. (KR) 2020-08-12 EP disclosed
CN-111479813-A Triazolobenzazepines as vasopressin V1A receptor antagonists 吉瑞工厂 2020-07-31 CN disclosed
CN-111315727-A Benzothiazole compounds and methods of using the same for treating neurodegenerative diseases 第一生物治疗股份有限公司 2020-06-19 CN disclosed
US-10669246-B2 Benzothiazol compounds and methods using the same for treating neurodegenerative disorders 1ST Biotherapeutics, Inc. (KR) 2020-06-02 US disclosed
US-20200079757-A1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES THE UNIVERSITY OF MELBOURNE (AU) 2020-03-12 US disclosed
WO-2019070093-A1 BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS 1ST Biotherapeutics, Inc. (KR) 2019-04-11 WO disclosed
US-20190100500-A1 BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS 1ST Biotherapeutics, Inc. 2019-04-04 US disclosed
EP-2980906-A1 Fluorinated carbamates as solvent for lithium-ion electrolytes Westfälische Wilhelms-Universität Münster (DE) 2016-02-03 EP disclosed
US-20110230419-A1 IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2011-09-22 US disclosed
US-6159640-A Electrolyte system for lithium batteries and use of said system, and method for increasing the safety of lithium batteries HOECHST RESEARCH & TECHNOLOGY GMBH & CO. KG (DE) 2000-12-12 US disclosed